Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: Implications for risk‐based therapeutic intensity trials
Keyword(s):
2016 ◽
Vol 94
(4)
◽
pp. 871
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):